Publication | Closed Access

An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

Prognostic BiomarkersHepatologyHepatocellular CarcinomaInflammation-based Prognostic ScoreMedicinePathologyLiver DiseaseLiver CancerOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchAdvanced Hepatocellular Carcinoma